ALLR

Allarity Therapeutics, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$5m30-Sep-2610-Q filed 13-Nov-26
Remaining authorization$5m30-Sep-2610-Q filed 13-Nov-26
Program expiry01-Mar-2730-Sep-2610-Q filed 13-Nov-26
Repurchased last quarter$030-Sep-2610-Q filed 13-Nov-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
26-Feb-26$5m$5m01-Mar-27On February 26, 2026, the board of directors approved a new share repurchase program ("the 2026 Share Repurchase Plan"), with authorization to purchase up to $5 million of the Company's outstanding shares of common stock over a twelve-month period ending March 1, 2027.10-Q filed 13-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. ≈$0
    Jul ’26
  2. Aug ’26
  3. ≈$0
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-260—$010-Q filed 13-Nov-26
31-Aug-260—$010-Q filed 13-Nov-26
31-Jul-260—$010-Q filed 13-Nov-26
Filings through 30-Sep-26· checked 17-Nov-26